Additional file 1 of Monitoring of prostate-specific antigen in men with benign prostate enlargement receiving 5-alpha reductase inhibitors: a non-interventional, cross-sectional study of real-world practice of urologists in Spain and Brazil
Supplementary Material 1: Supplementary Methods. Supplementary Table 1. Questions used in questionnaire and PRFs to address the study objectives. Supplementary Table 2. Characteristics of urologists who completed the questionnaire.
Institutions
- IQVIA (United Kingdom) (GB)
- Hospital Universitari i Politècnic La Fe (ES)
- Universidade do Estado do Rio de Janeiro (BR)
- GlaxoSmithKline (India) (IN)
- IQVIA (United States) (US)
- GlaxoSmithKline (Spain) (ES)
- Pontifícia Universidade Católica do Rio Grande do Sul (BR)
Publication Details
- Journal
- Figshare
- Published
- 2025-01-01
- DOI
- https://doi.org/10.6084/m9.figshare.28327747
- Primary Topic
- Wheat and Barley Genetics and Pathology
- Type
- article
- Field-Weighted Citation Impact
- 0.00